© Reuters. Used vials of the Pfizer-BioNTech, Moderna and AstraZeneca coronavirus illness (COVID-19) vaccines are pictured on the Skane College Hospital vaccination centre in Malmo, Sweden, February 17, 2021. TT Information Company/Johan Nilsson through REUTERS ATTENTION EDI
STOCKHOLM (Reuters) – Sweden’s Public Well being Company stated on Monday it beneficial the usage of Pfizer-BioNTech’s, Comirnaty vaccine in opposition to COVID-19 for youngsters between 12-15, opting in opposition to rival Moderna (NASDAQ:)’s Spikevax.
The European Medicines Company accepted the usage of Comirnaty in Could, whereas Spikevax was given the nod for youngsters over 12 in July.
“All in all, we see motive to decide on the vaccine that we all know probably the most about and that’s most well-proven in terms of vaccinating kids between 12 and 15 years of age,” Anders Tegnell, head of division and state epidemiologist on the Well being Company stated.
The company stated there was extra knowledge about Comirnaty’s use on kids.
“That is why Spikevax isn’t beneficial for the youngest age group in Sweden,” the Company stated in a press release.
In September, the Company stated that kids aged 12 and over can be supplied a COVID vaccination beginning Oct. 11.
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or harm on account of reliance on the knowledge together with knowledge, quotes, charts and purchase/promote indicators contained inside this web site. Please be absolutely knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is likely one of the riskiest funding types doable.